Home › Trial NCT07817173
Feasibility of HISA During TURBT for NMIBC
- Trial IDNCT07817173
- StatusNot Yet Recruiting
- PhaseN/A
- Study typeInterventional
- SponsorCAMC Health System
- Enrollment40
- Start date2026-08-15
- ConditionsBladder Cancer · Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy) · Non-muscle Invasive Bladder Cancer (NMIBC) · Non-Muscle Invasive Bladder Neoplasms · Non-muscle Invasive Bladder Cancer · Bladder Cancer (BC)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.